TECNIS IOL ZLU150 (REF ZLU150U240)Recalls & reported problems
Johnson & Johnson Surgical Vision, Inc. · TECNIS TORIC LOW ADD 1-PC 24.0D CYL1.50 · Class 3 · Implant
All models of TECNIS IOL (1344)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 05050474689442), received between Jun 3, 2026 and Jun 3, 2026 — classified as 1 injury.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Blurred Vision1
- Dry Eye(s)1
- Eye Irritation1
- Halo1
- Posterior Capsule Opacification1
- Visual Disturbances1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryJun 3, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT A MULTIFOCAL TORIC INTRAOCULAR LENS (IOL) WAS IMPLANTED IN THE PATIENT¿S RIGHT EYE. FOLLOWING IMPLANTATION, THE PATIENT EXPERIENCED PERSISTENT HALOS, GLARE, INTERMITTENT IRRITATION/DRYNESS AND BLURRY VISION, DESCRIBED AS CONTINUOUS AND PROGRESSIVELY WORSENING, RESULTING IN DECREASED QUALITY OF BOTH DISTANCE AND NEAR VISION AND IMPACTING DAILY ACTIVITIES. CONSERVATIVE MANAGEMENT, INCLUDING OCULAR SURFACE TREATMENT AND PHARMACOLOGIC THERAPY (VUITY), DID NOT PROVIDE ADEQUATE IMPROVEMENT. THE PATIENT ULTIMATELY ELECTED TO PROCEED WITH RIGHT EYE IOL EXCHANGE TO A MONOFOCAL LENS AND SUBSEQUENTLY THE LENS WAS EXPLANTED. THE PROCEDURE WAS SUCCESSFULLY COMPLETED WITH IMPLANTATION OF A REPLACEMENT INTRAOCULAR LENS (MODEL DIU150) OF THE SAME DIOPTER POWER AS THE ORIGINAL LENS. TWO 10-0 NYLON SUTURES WERE PLACED TO SECURE WOUND CLOSURE DURING THE IOL EXCHANGE PROCEDURE. NO VITRECTOMY OR OTHER UNPLANNED SURGICAL INTERVENTIONS WERE REQUIRED, AND NO MEDICATIONS OUTSIDE THE STANDARD OF CARE WERE PRESCRIBED. NO ADDITIONAL SURGICAL PROCEDURES ARE PLANNED. NO PATIENT INJURY, INCLUDING CAPSULAR TEAR WAS REPORTED AND NO USER HARM WAS IDENTIFIED. IT WAS INDICATED THAT THE VISUAL SYM
Patient problems: Blurred Vision; Dry Eye(s); Eye Irritation; Halo; Posterior Capsule Opacification; Visual Disturbances
MAUDE report 25384016 ↗
Other Lens, multifocal intraocular devices
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular144 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular1 recall66 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular113 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular112 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular110 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular107 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular104 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular93 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page